Recent News

• 12.01.2025 - MindMed Announces New Employee Inducement Grants
• 11.06.2025 - MindMed Reports Q3 2025 Financial Results and Business Updates
• 11.05.2025 - MindMed to Participate in Upcoming Investor Conferences
• 11.03.2025 - MindMed Announces New Employee Inducement Grant
• 11.03.2025 - Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
• 10.30.2025 - MindMed to Report Q3 2025 Financial Results on November 6, 2025
• 10.30.2025 - Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering
• 10.29.2025 - Mind Medicine (MindMed) Inc. Announces Proposed Public Offering
• 10.14.2025 - MindMed Announces New Employee Inducement Grant

Recent Filings

• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.06.2025 - EX-99.1 EX-99.1
• 11.06.2025 - 8-K Current report
• 10.31.2025 - EX-99.1 EX-99.1
• 10.31.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 10.31.2025 - 8-K Current report
• 10.29.2025 - 8-K Current report
• 10.29.2025 - EX-99.1 EX-99.1
• 10.29.2025 - 424B5 Prospectus [Rule 424(b)(5)]